Specialty | Gotoper.com

Customize

Back to Homepage

Quick Links

Why CME?

Specialties

2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2019
Physicians’ Education Resource ®, LLC.
All rights reserved.

All Activities

Cancer Summaries and Commentaries™: Update from Munich: Advances in the Treatment of Lung Cancer, Genitourinary Malignancies, and Gynecologic Malignancies

Faculty: Bernard Escudier, MD; David R. Gandara, MD; Richard T. Penson, MD

Expires on December 30, 2019

CME: 2.25

Oncology Consultations® in Ovarian Cancer: Differentiating Among Clinical Trial Designs to Match PARP to Patient

Faculty: Susana Campos, MD; Shannon N. Westin, MD, MPH, FACOG

Expires on October 31, 2019

CME: 1.5

Enduring CME activity from the September 4, 2018, Live Webcast: Meeting Unmet Clinical Needs in Cervical Cancer: Paving a New Course in Advanced Disease Settings With Immune-Based Strategies

Faculty: Bradley J. Monk, MD, FACS, FACOG; Linda R. Duska, MD, MPH, FACOG; Shannon N. Westin, MD, MPH, FACOG; Krishnansu S. Tewari, MD, FACOG, FACS, FRSM

Expires on September 28, 2019

CME: 1.5

Community Practice Connections™: 2nd Annual School of Nursing Oncology™

Faculty: Grace Cherry, RN, MSN, NP; Beth Eaby-Sandy, MSN, CRNP, OCN; Laura S. Wood, RN, MSN, OCN

Expires on September 28, 2019

CNE: 1.5

CME: 1.5

Community Practice Connections™: 2nd Annual International Congress on Oncology Pathology™

Faculty: Alain Borczuk, MD; Balazs Halmos, MD; Daniel P. Petrylak, MD

Expires on August 31, 2019

CNE: 1.5

CME: 1.5

Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis Syndrome

Faculty: Mitchell S. Cairo, MD

Expires on June 30, 2019

CME: 1.0

Community Practice Connections™: Show Me the Data™: Leveraging Evidence to Optimize Applications of PARP Inhibitor Strategies in Ovarian Cancer

Faculty: Robert L. Coleman, MD, FACOG, FACS; Ursula A. Matulonis, MD ; Bradley J. Monk, MD, FACS, FACOG

Expires on June 29, 2019

CME: 1.5

Live Meetings

3rd Annual International Congress on Oncology Pathology™: Towards Harmonization of Pathology and Oncology Standards

June 22, 2019
New York, NY

3rd Annual School of Nursing Oncology™

August 2-3, 2019
San Diego, CA

SUN	MON	TUES	WED	THURS	FRI	SAT
	1 Molecular Tumor Board in EGFR Mutation–Positive Lung Cancers: Integrating Clinical Data Into Patient Care April 1, 2019 Atlanta, GA CME 2.0	2	3	4	5	6
7	8	9	10 Cutting CVD Risk by Adding PCSK9 Inhibitors: What the Internist Needs to Know April 10, 2019 Philadelphia, PA CME 2.0 ONS: Onco-Nurse Academy™: 101 on CAR T-Cell Therapies April 10, 2019 Anaheim, CA CME 1.5 ONS: Nursing Essentials: Optimized Care Strategies for the Patient With Advanced Renal Cell Carcinoma April 10, 2019 Anaheim, CA	11	12 ONS: Working Group to Optimize Outcomes in Myelofibrosis and Polycythemia Vera: Real-World Applications for Nurses April 12, 2019 Anaheim, CA CME 1.5 ONS: Optimizing Outcomes in Melanoma with BRAF/MEK Inhibitor and Immunotherapeutic Strategies: Essentials for the Onco-Nurse April 12, 2019 Anaheim, CA CME 1.5 ONS: Recognizing and Treating Oncologic Emergencies in the Cancer Patient: What Does the Nurse Need to Know? April 12, 2019 Anaheim, CA CME 1.5	13
14	15	16 AML Year in Review™: Live Webcast Around the World Expires on Apr 16, 2019 CME 2.0	17	18	19	20
21	22	23	24	25	26	27 4th Annual School of Gastrointestinal Oncology™ (SOGO®) April 27, 2019 Washington, DC CME 7.25
28	29	30 Oncology Consultations®: The Advancing Role of CAR T-Cell Therapies in Hematologic Malignancies Expires on Apr 30, 2019 CME 1.5 Advances in™ Diagnostic Guidelines for Effective Clinical Decision - Making in the Management of Hematologic Malignancies Expires on Apr 30, 2019 CME 1.5 Community Practice Connections™: Emerging Paradigm Shifts in Renal Cell Carcinoma: A Critical Assessment of Adjuvant Treatment Data Expires on Apr 30, 2019 CME 1.5 Community Practice Connections™: 14th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® Expires on Apr 30, 2019 CME 2.0 Community Practice Connections™: Personalized Assessment in Advanced RCC Decision Making: Leveraging the Evidence and Patient Characteristics to Inform Decisions Along the Disease Continuum Expires on Apr 30, 2019 CME 1.5

4th Annual School of Gastrointestinal Oncology™ (SOGO®)

4th Annual School of Gastrointestinal Oncology™ (SOGO^®)